COMMUNIQUÉS West-GlobeNewswire

-
Theriva™ Biologics Announces Positive Topline Data from Investigator Sponsored Phase 1 Trial of Intravitreal VCN-01 in Pediatric Patients with Refractory Retinoblastoma
23/04/2024 -
Option Care Health Announces Financial Results for the First Quarter Ended March 31, 2024
23/04/2024 -
AVEROA Submits Marketing Authorisation Application to the European Medicines Agency Seeking Approval of AVA1014 for Treating Complications Associated with Chronic Kidney Disease
23/04/2024 -
CDR-Life to Present Tumor Targeting Capabilities of M-gager® Platform at the TCR-Based Therapies for Solid Tumors Summit
23/04/2024 -
ITM, Helmholtz Munich and University Hospital Münster Announce First Patient Dosed in Phase I Investigator-Initiated Glioblastoma Trial
23/04/2024 -
Sequana Medical announces the Annual and Extraordinary General Meetings of Shareholders on 23 May 2024
23/04/2024 -
AAVantgarde presents positive preclinical data in large animal models from its Stargardt disease program in an oral presentation at the ASGCT 2024 annual meeting
23/04/2024 -
Sequana Medical announces the Annual and Extraordinary General Meetings of Shareholders on 23 May 2024
23/04/2024 -
Sequana Medical announces Annual General Meeting of Shareholders on 25 May 2023
23/04/2024 -
Novartis delivers double-digit sales growth and core margin expansion in Q1; FY 2024 guidance raised
23/04/2024 -
Novartis, au premier trimestre: croissance à deux chiffres du chiffre d’affaires et expansion de la marge core; hausse des prévisions pour 2024
23/04/2024 -
Idorsia publishes an invitation to a bondholder meeting
23/04/2024 -
Press Release: Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia
23/04/2024 -
Communiqué de presse : L’étude de phase III LUNA 3 du rilzabrutinib pour le traitement de la thrombocytopénie immune a atteint son critère d’évaluation primaire
23/04/2024 -
Curium Enrolls First Prostate Cancer Patients in its Phase 3 SOLAR Trials
23/04/2024 -
Regeneron to Highlight Advances in Genetic Medicine Research at American Society of Gene and Cell Therapy (ASGCT)
22/04/2024 -
Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
22/04/2024 -
Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
22/04/2024 -
Arbor Biotechnologies to Present Data Supporting Therapeutic Programs in PH1 and ALS, and the Discovery of a Novel Type V Nuclease at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
22/04/2024
Pages